Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
Infectious diseases are linked to 15%−20% of cancers worldwide. Among them, Epstein−Barr virus (EBV) is an oncogenic herpesvirus that chronically infects over 90% of the adult population, with over 200,000 cases of cancer and 150,000 cancer-related deaths attributed to it yearly....
Main Authors: | Krzysztof Wojtak, Alfredo Perales-Puchalt, David B. Weiner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/7/2/44 |
Similar Items
-
Epstein–Barr Virus B Cell Growth Transformation: The Nuclear Events
by: Bo Zhao
Published: (2023-03-01) -
DETECTION OF EPSTEIN-BARR VIRUS GENOME IN ORAL CAVITY SQUAMOUS CELL CARCINOMA SAMPLES OF RUSSIAN PATIENTS
by: S. A. Kiryanov, et al.
Published: (2019-06-01) -
Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
by: Katerina Vrzalikova, et al.
Published: (2018-08-01) -
EPSTEIN–BARR VIRUS IN THE POPULATION OF TWO GEOGRAPHICALLY DIFFERENT REGIONS OF RUSSIA
by: N. B. Senyuta, et al.
Published: (2017-03-01) -
Phylodynamic characteristics of the LMP-1 gene of the Epstein–Barr virus isolated in the Nizhny Novgorod region
by: Daria A. Bryzgalova, et al.
Published: (2023-11-01)